PatientSafe Solutions, a US-based hospital safety company backed by local drugs group Merck’s corporate venturing unit, has raised $20m in its series C round. Last month, PatientSafe said it had raised $13m, according to an updated filing with the Securities and Exchange Commission. Merck’s Global Health Innovation (GHI) fund led the C round and was…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
